◀ Back to MAPK1
KIT — MAPK1
Pathways - manually collected, often from reviews:
Text-mined interactions from Literome
Tsao et al., Cancer 2003
(Hypopigmentation...) :
The signal transduction mechanism currently is believed to involve SCF ligand binding of
KIT and downstream
activation of MAP kinase (
Erk-2 )
Zhu et al., Oncogene 2007
(Gastrointestinal Stromal Tumors) :
Activated signaling intermediates were identified by immunoaffinity purification of tyrosine phosphorylated proteins in GIST cells before and after treatment with KIT inhibitors, and these analyses show that GRB2, SHC, CBL and
MAPK activation are largely
KIT dependent in GISTs, whereas PI3-K, STAT1 and STAT3 activation are partially KIT dependent